United States · Series C startup

Who invested in Endovascular Engineering, Inc. (“E2”)

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Medical Devices

Raised 7 months ago

Funding summaryUpdated 5 Nov 2026

$80Mraised across 1 round since 2026, from 3 sources

Latest round
Series C, $80MApr 2026
Led by
Norwest Venture Partners and Gilde Healthcare
Investors
7 (2 led)
See who backed them

The rounds

  1. Apr 2026
    Series C$80M

    Reported by Firms' own news pages and 2 others

Everyone who backed them

Norwest Venture PartnersVC firm1round, led 1
Gilde HealthcarePrivate equity1round, led 1
Sante VenturesVC firm1round
S3 VenturesVC firm1round
Panakes PartnersVC firm1round
415 CapitalVC firm1round
M&L Healthcare InvestmentsFamily office1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Endovascular Engineering, Inc. (“E2”)

Who invested in Endovascular Engineering, Inc. (“E2”)?

Endovascular Engineering, Inc. (“E2”)'s investors include Norwest Venture Partners, Gilde Healthcare, Sante Ventures, S3 Ventures and Panakes Partners, and 2 more on record. Norwest Venture Partners led its latest round.

How much has Endovascular Engineering, Inc. (“E2”) raised?

Endovascular Engineering, Inc. (“E2”) has raised $80M across 1 round since 2026.

When did Endovascular Engineering, Inc. (“E2”) last raise?

Endovascular Engineering, Inc. (“E2”)'s most recent round was a Series C of $80M in Apr 2026, led by Norwest Venture Partners.

What was Endovascular Engineering, Inc. (“E2”)'s biggest round?

Its most recent round, $80M in Apr 2026, is also its largest on record.

Who backed Endovascular Engineering, Inc. (“E2”) first?

Endovascular Engineering, Inc. (“E2”)'s first round on record, in Apr 2026, was backed by Norwest Venture Partners, Gilde Healthcare and Sante Ventures and 4 others.

What stage is Endovascular Engineering, Inc. (“E2”) at?

Endovascular Engineering, Inc. (“E2”)'s latest named round is a Series C, in Apr 2026.

Where is Endovascular Engineering, Inc. (“E2”) based?

Endovascular Engineering, Inc. (“E2”) is based in the United States.

Who led Endovascular Engineering, Inc. (“E2”)'s rounds?

Norwest Venture Partners led the Series C in 2026.

Companies like Endovascular Engineering, Inc. (“E2”)

In the same sector, and raised in the last eighteen months.

Laza Medical$160M · Nov 2026GT Metabolic Solutions$17M · Oct 2026Urologic Design$1.2M · Oct 2026Parasol$4.8M · Oct 2026Promaxo$106M · Oct 2026Stride$16M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app